4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide

C32H31N9O4 — CID 143817820

IUPAC4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide
SMILESCc1c(C2=NNNN2)ccc2c1CCC2NC(=O)c1cc(C(=O)NCc2ccc3c(c2)CN(c2c(C)c(=O)c2=O)CC3)ncn1
InChIInChI=1S/C32H31N9O4/c1-16-21-7-8-24(23(21)6-5-22(16)30-37-39-40-38-30)36-32(45)26-12-25(34-15-35-26)31(44)33-13-18-3-4-19-9-10-41(14-20(19)11-18)27-17(2)28(42)29(27)43/h3-6,11-12,15,24,39-40H,7-10,13-14H2,1-2H3,(H,33,44)(H,36,45)(H,37,38)
InChIKeyOETBCAZHHARTFG-UHFFFAOYSA-N
MW605.66 g/mol
LogP0.87
Rot. Bonds7

About 4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide

4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide (PubChem CID 143817820) has the molecular formula C32H31N9O4 and a molecular weight of 605.66 g/mol. Its IUPAC name is 4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide.

Molecular Properties

Compound Name4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide
PubChem CID143817820
Molecular FormulaC32H31N9O4
Molecular Weight605.66 g/mol
Exact Mass605.25
IUPAC Name4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide
SMILESCc1c(C2=NNNN2)ccc2c1CCC2NC(=O)c1cc(C(=O)NCc2ccc3c(c2)CN(c2c(C)c(=O)c2=O)CC3)ncn1
InChIInChI=1S/C32H31N9O4/c1-16-21-7-8-24(23(21)6-5-22(16)30-37-39-40-38-30)36-32(45)26-12-25(34-15-35-26)31(44)33-13-18-3-4-19-9-10-41(14-20(19)11-18)27-17(2)28(42)29(27)43/h3-6,11-12,15,24,39-40H,7-10,13-14H2,1-2H3,(H,33,44)(H,36,45)(H,37,38)
InChIKeyOETBCAZHHARTFG-UHFFFAOYSA-N
XLogP0.87
TPSA169.81 Ų
H-Bond Donors5
H-Bond Acceptors11
Rotatable Bonds7
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500605.66
LogP ≤ 50.87
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze 4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide?
The IUPAC name of 4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide (CID 143817820) is 4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide.
What is the SMILES notation for 4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide?
The canonical SMILES for 4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide is Cc1c(C2=NNNN2)ccc2c1CCC2NC(=O)c1cc(C(=O)NCc2ccc3c(c2)CN(c2c(C)c(=O)c2=O)CC3)ncn1.
What is the InChIKey of 4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide?
The InChIKey is OETBCAZHHARTFG-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H31N9O4/c1-16-21-7-8-24(23(21)6-5-22(16)30-37-39-40-38-30)36-32(45)26-12-25(34-15-35-26)31(44)33-13-18-3-4-19-9-10-41(14-20(19)11-18)27-17(2)28(42)29(27)43/h3-6,11-12,15,24,39-40H,7-10,13-14H2,1-2H3,(H,33,44)(H,36,45)(H,37,38).
What are the key properties of 4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide?
4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide has a molecular weight of 605.66 g/mol, XLogP of 0.87, 7 rotatable bonds, 5 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 4-N-[5-(2,3-dihydro-1H-tetrazol-5-yl)-4-methyl-2,3-dihydro-1H-inden-1-yl]-6-N-[[2-(2-methyl-3,4-dioxocyclobuten-1-yl)-3,4-dihydro-1H-isoquinolin-7-yl]methyl]pyrimidine-4,6-dicarboxamide is sourced from PubChem (CID 143817820), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).